therapeuticЮжно-Российский журнал терапевтической практикиSouth Russian Journal of Therapeutic Practice2712-81563033-8344РостГМУ10.21886/2712-8156-2022-3-2-19-24therapeutic-246Research ArticleОБЗОРЫREVIEWSГиперурикемия как предиктор неалкогольной жировой болезни печениHyperuricemia as a predictor of non-alcoholic fatty liver diseasehttps://orcid.org/0000-0002-3306-0312СтаценкоМ. Е.StatsenkoM. E.

Стаценко Михаил Евгеньевич, д.м.н., проф., зав. кафедрой внутренних болезней

Волгоград

Statsenko Mikhail Evgenievich, Dr. Sci. (Med.), prof, professor of internal diseases department

Volgograd

mestatsenko@rambler.ruhttps://orcid.org/0000-0002-8844-2465ТуркинаС. В.TurkinaS. V.

Туркина Светлана Владимировна, д.м.н., профессор кафедры внутренних болезней

Волгоград

Turkina Svetlana Vladimirovna, Dr. Sci. (Med.), professor of internal diseases department

Volgograd

turkinasv@rambler.ruhttps://orcid.org/0000-0001-7161-0381УстиноваМ. Н.UstinovaM. N.

Устинова Маргарита Николаевна, к.м.н., доцент кафедры внутренних болезней

Волгоград

Ustinova Margarita Nikolaevna, Cand. Sci. (Med.), associate professor of internal diseases department

Volgograd

ustinovavolgmed@yandex.ruhttps://orcid.org/0000-0002-5947-7992ТумаренкоА. В.TumarenkoA. V.

Тумаренко Александр Владимирович, к.м.н., доцент кафедры внутренних болезней

Волгоград

Tumarenko Alexandr Vladimirovich, Cand. Sci. (Med.), associate professor of internal diseases department

Volgograd

al.volga2017@yandex.ruhttps://orcid.org/0000-0003-1564-0599СвириденкоО. Ю.SviridenkoO. Yu.

Свириденко Олег Юрьевич, к.м.н., доцент кафедры внутренних болезней

Волгоград

Sviridenko Oleg Yuryevich, Cand. Sci. (Med.), associate professor of internal diseases department

Volgograd

sviridenko_53@mail.ruhttps://orcid.org/0000-0002-1077-5489СвириденкоА. О.SviridenkoA. O.

Свириденко Антон Олегович, ассистент кафедры внутренних болезней

Волгоград

Sviridenko Anton Olegovich, assistant of professor of internal diseases department

Volgograd

sviridenko.antVOKB@yandex.ruФГБОУ ВО «Волгоградский государственный медицинский университет» Минздрава РФРоссияVolgograd State Medical UniversityRussian Federation202218062022321924Copyright © Стаценко М.Е., Туркина С.В., Устинова М.Н., Тумаренко А.В., Свириденко О.Ю., Свириденко А.О., 20222022Стаценко М.Е., Туркина С.В., Устинова М.Н., Тумаренко А.В., Свириденко О.Ю., Свириденко А.О.Statsenko M.E., Turkina S.V., Ustinova M.N., Tumarenko A.V., Sviridenko O.Y., Sviridenko A.O.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.therapeutic-j.ru/jour/article/view/246

Неалкогольная жировая болезнь печени (НАЖБП) в настоящее время представляет собой широко распространённое среди взрослого населения заболевание и, являясь компонентом метаболического синдрома (МС), часто ассоциируется с ожирением, инсулинорезистентностью (ИР), сахарным диабетом 2 типа (СД2), сердечно-сосудистыми заболеваниями (ССЗ). Многими авторами в научных исследованиях обнаружено, что гиперурикемия (ГУ) может рассматриваться как предиктор неалкогольной жировой болезни печени (НАЖБП), а также других заболеваний, связанных с метаболическим синдромом (МС).

Non-alcoholic fatty liver disease (NAFLD) is currently a widespread disease among the adult population and, being a component of the metabolic syndrome (MS), is often associated with obesity, insulin resistance (IR), type 2 diabetes mellitus (DM2), cardiovascular diseases (CVD). Many authors in scientific studies have found that hyperuricemia (HU) can be considered as a predictor of non-alcoholic fatty liver disease (NAFLD), as well as other diseases associated with metabolic syndrome (MS).

неалкогольная жировая болезнь печенигиперурикемияметаболический синдроможирениеинсулинорезистентностьсахарный диабет 2 типасердечно-сосудистые заболеванияnon-alcoholic fatty liver diseasehyperuricemiametabolic syndromeobesityinsulin resistancetype 2 diabetescardiovascular diseasesReferencesBedogni G, Nobili V, Tiribelli C. Epidemiology of fatty liver: an update. World J Gastroenterol. (2014) 20:9050–4. DOI: 10.3748/wjg.v20.i27.9050Bedogni G, Nobili V, Tiribelli C. Epidemiology of fatty liver: an update. World J Gastroenterol. (2014) 20:9050–4. DOI: 10.3748/wjg.v20.i27.9050Liu Y, Liu C, Shi X, Lin M, Yan B, Zeng X, et al. Correlations of non-alcoholic fatty liver disease and serum uric acid with subclinical atherosclerosis in obese Chinese adults. J Diabetes. (2017) 9:586–95. DOI: 10.1111/1753-0407.12441Liu Y, Liu C, Shi X, Lin M, Yan B, Zeng X, et al. Correlations of non-alcoholic fatty liver disease and serum uric acid with subclinical atherosclerosis in obese Chinese adults. J Diabetes. (2017) 9:586–95. DOI: 10.1111/1753-0407.12441Li LX, Dong XH, Li MF, Zhang R, Li TT, Shen J, et al. Serum uric acid levels are associated with hypertension and metabolic syndrome but not atherosclerosis in Chinese inpatients with type 2 diabetes. J Hypertens. 2015;33(3):482-90; discussion 490. DOI: 10.1097/HJH.0000000000000417Li LX, Dong XH, Li MF, Zhang R, Li TT, Shen J, et al. Serum uric acid levels are associated with hypertension and metabolic syndrome but not atherosclerosis in Chinese inpatients with type 2 diabetes. J Hypertens. 2015;33(3):482-90; discussion 490. DOI: 10.1097/HJH.0000000000000417Wu AH, Gladden JD, Ahmed M, Ahmed A, Filippatos G. Relation of serum uric acid to cardiovascular disease. Int J Cardiol. (2016) 213:4–7. DOI: 10.1016/jijcard.2015.08.110Wu AH, Gladden JD, Ahmed M, Ahmed A, Filippatos G. Relation of serum uric acid to cardiovascular disease. Int J Cardiol. (2016) 213:4–7. DOI: 10.1016/jijcard.2015.08.110Li C, Hsieh MC, Chang SJ. Metabolic syndrome, diabetes, and hyperuricemia. Curr Opin Rheumatol. (2013) 25:210–6. DOI: 10.1097/BOR.0b013e32835d951eLi C, Hsieh MC, Chang SJ. Metabolic syndrome, diabetes, and hyperuricemia. Curr Opin Rheumatol. (2013) 25:210–6. DOI: 10.1097/BOR.0b013e32835d951eYe X, Cao Y, Gao F, Yang Q, Zhang Q, Fu X, et al. Elevated serum uric acid levels are independent risk factors for diabetic foot ulcer in female Chinese patients with type 2 diabetes. J Diabetes. (2014) 6:42–7. DOI: 10.1111/1753-0407.12079Ye X, Cao Y, Gao F, Yang Q, Zhang Q, Fu X, et al. Elevated serum uric acid levels are independent risk factors for diabetic foot ulcer in female Chinese patients with type 2 diabetes. J Diabetes. (2014) 6:42–7. DOI: 10.1111/1753-0407.12079Choi H, Kim HC, Song BM, Park JH, Lee JM, Yoon DL, et al. Serum uric acid concentration and metabolic syndrome among elderly Koreans: the Korean Urban Rural Elderly (KURE) study. Arch Gerontol Geriatr. (2016) 64:51–8. DOI: 10.1016/j.archger.2016.01.005Choi H, Kim HC, Song BM, Park JH, Lee JM, Yoon DL, et al. Serum uric acid concentration and metabolic syndrome among elderly Koreans: the Korean Urban Rural Elderly (KURE) study. Arch Gerontol Geriatr. (2016) 64:51–8. DOI: 10.1016/j.archger.2016.01.005Yuan H, Yu C, Li X, Sun L, Zhu X, Zhao C, et al. Serum uric acid levels and risk of Metabolic Syndrome: A dose-response meta-analysis of prospective studies. J Clin Endocrinol Metab. (2015) 100:4198–207. DOI: 10.1210/jc2015-2527Yuan H, Yu C, Li X, Sun L, Zhu X, Zhao C, et al. Serum uric acid levels and risk of Metabolic Syndrome: A dose-response meta-analysis of prospective studies. J Clin Endocrinol Metab. (2015) 100:4198–207. DOI: 10.1210/jc2015-2527Richette P, Perez-Ruiz F. Serum uric acid and metabolic risk. Curr Med Res Opin. (2013) 29:9–15. DOI: 10.1185/03007995.2013.790801Richette P, Perez-Ruiz F. Serum uric acid and metabolic risk. Curr Med Res Opin. (2013) 29:9–15. DOI: 10.1185/03007995.2013.790801Ryu S, Chang Y, Kim SG, Cho J, Guallar E. Serum uric acid levels predict incident nonalcoholic fatty liver disease in healthy Korean men. Metabolism. 2011;60(6):860-6. DOI: 10.1016/j.metabol.2010.08.005Ryu S, Chang Y, Kim SG, Cho J, Guallar E. Serum uric acid levels predict incident nonalcoholic fatty liver disease in healthy Korean men. Metabolism. 2011;60(6):860-6. DOI: 10.1016/j.metabol.2010.08.005Cai W, Song JM, Zhang B, Sun YP, Yao H, Zhang YX. The prevalence of nonalcoholic fatty liver disease and relationship with serum uric acid level in Uyghur population. ScientificWorldJournal. 2014;2014:393628. DOI: 10.1155/2014/393628.Cai W, Song JM, Zhang B, Sun YP, Yao H, Zhang YX. The prevalence of nonalcoholic fatty liver disease and relationship with serum uric acid level in Uyghur population. ScientificWorldJournal. 2014;2014:393628. DOI: 10.1155/2014/393628.Petta S, Camma C, Cabibi D, Di Marco V, Craxi A. Hyperuricemia is associated with histological liver damage in patients with non-alcoholic fatty liver disease. Aliment Pharmacol Ther. 2011;34(7):757–66. DOI: 10.1111/j.1365-2036.2011.04788.Petta S, Camma C, Cabibi D, Di Marco V, Craxi A. Hyperuricemia is associated with histological liver damage in patients with non-alcoholic fatty liver disease. Aliment Pharmacol Ther. 2011;34(7):757–66. DOI: 10.1111/j.1365-2036.2011.04788.Kuo CF, Yu KH, Luo SF, Chiu CT, Ko YS, Hwang JS, et al. Gout and risk of non-alcoholic fatty liver disease. Scandinavian journal of rheumatology. 2010;39(6):466–71. DOI: 10.3109/03009741003742797.Kuo CF, Yu KH, Luo SF, Chiu CT, Ko YS, Hwang JS, et al. Gout and risk of non-alcoholic fatty liver disease. Scandinavian journal of rheumatology. 2010;39(6):466–71. DOI: 10.3109/03009741003742797.Vos MB, Colvin R, Belt P, Molleston JP, Murray KF, Rosenthal P, et al. Correlation of vitamin E, uric acid, and diet composition with histologic features of pediatric NAFLD. J Pediatr Gastroenterol Nutr. 2012;54(1):90-6. DOI: 10.1097/MPG.0b013e318229da1a.Vos MB, Colvin R, Belt P, Molleston JP, Murray KF, Rosenthal P, et al. Correlation of vitamin E, uric acid, and diet composition with histologic features of pediatric NAFLD. J Pediatr Gastroenterol Nutr. 2012;54(1):90-6. DOI: 10.1097/MPG.0b013e318229da1a.Xu C, Yu C, Xu L, Miao M, Li Y. High serum uric acid increases the risk for nonalcoholic Fatty liver disease: a prospective observational study. PLoS One. 2010;5(7):e11578. DOI: 10.1371/journal.pone.0011578.Xu C, Yu C, Xu L, Miao M, Li Y. High serum uric acid increases the risk for nonalcoholic Fatty liver disease: a prospective observational study. PLoS One. 2010;5(7):e11578. DOI: 10.1371/journal.pone.0011578.Lee JW, Cho YK, Ryan M, Kim H, Lee SW, Chang E, et al. Serum uric Acid as a predictor for the development of nonalcoholic Fatty liver disease in apparently healthy subjects: a 5-year retrospective cohort study. Gut Liver. 2010;4(3):378-83. DOI: 10.5009/gnl.2010.4.3.378.Lee JW, Cho YK, Ryan M, Kim H, Lee SW, Chang E, et al. Serum uric Acid as a predictor for the development of nonalcoholic Fatty liver disease in apparently healthy subjects: a 5-year retrospective cohort study. Gut Liver. 2010;4(3):378-83. DOI: 10.5009/gnl.2010.4.3.378.Xie Y, Wang M, Zhang Y, Zhang S, Tan A, Gao Y, et al. Serum uric acid and non-alcoholic fatty liver disease in non-diabetic Chinese men. PLoS One. 2013;8(7):e67152. doi: 10.1371/journal.pone.0067152Xie Y, Wang M, Zhang Y, Zhang S, Tan A, Gao Y, et al. Serum uric acid and non-alcoholic fatty liver disease in non-diabetic Chinese men. PLoS One. 2013;8(7):e67152. doi: 10.1371/journal.pone.0067152Chen CH, Huang MH, Yang JC, Nien CK, Yang CC, Yeh YH, et al. Prevalence and risk factors of nonalcoholic fatty liver disease in an adult population of taiwan: metabolic significance of nonalcoholic fatty liver disease in nonobese adults. J Clin Gastroenterol. 2006;40(8):745-52. DOI: 10.1097/00004836-200609000-00016.Chen CH, Huang MH, Yang JC, Nien CK, Yang CC, Yeh YH, et al. Prevalence and risk factors of nonalcoholic fatty liver disease in an adult population of taiwan: metabolic significance of nonalcoholic fatty liver disease in nonobese adults. J Clin Gastroenterol. 2006;40(8):745-52. DOI: 10.1097/00004836-200609000-00016.Liu PJ, Ma F, Lou HP, Zhu YN, Chen Y. Relationship between serum uric acid levels and hepatic steatosis in non-obese postmenopausal women. Climacteric. 2014;17(6):692–9. DOI: 10.3109/13697137.2014.926323Liu PJ, Ma F, Lou HP, Zhu YN, Chen Y. Relationship between serum uric acid levels and hepatic steatosis in non-obese postmenopausal women. Climacteric. 2014;17(6):692–9. DOI: 10.3109/13697137.2014.926323Cho HC. Prevalence and Factors Associated with Nonalcoholic Fatty Liver Disease in a Nonobese Korean Population. Gut Liver. 2016;10(1):117–25. DOI: 10.5009/gnl14444Cho HC. Prevalence and Factors Associated with Nonalcoholic Fatty Liver Disease in a Nonobese Korean Population. Gut Liver. 2016;10(1):117–25. DOI: 10.5009/gnl14444Nakatsu Y, Seno Y, Kushiyama A, Sakoda H, Fujishiro M, Katasako A, et al. The xanthine oxidase inhibitor febuxostat suppresses development of nonalcoholic steatohepatitis in a rodent model. Am J Physiol Gastrointest Liver Physiol. 2015;309(1):G42-51. DOI: 10.1152/ajpgi.00443.2014.Nakatsu Y, Seno Y, Kushiyama A, Sakoda H, Fujishiro M, Katasako A, et al. The xanthine oxidase inhibitor febuxostat suppresses development of nonalcoholic steatohepatitis in a rodent model. Am J Physiol Gastrointest Liver Physiol. 2015;309(1):G42-51. DOI: 10.1152/ajpgi.00443.2014.Kanbay M, Jensen T, Solak Y, Le M, Roncal-Jimenez C, Rivard C, et al. Uric acid in metabolic syndrome: From an innocent bystander to a central player. Eur J Intern Med. 2016;29:3-8. DOI: 10.1016/j.ejim.2015.11.026.Kanbay M, Jensen T, Solak Y, Le M, Roncal-Jimenez C, Rivard C, et al. Uric acid in metabolic syndrome: From an innocent bystander to a central player. Eur J Intern Med. 2016;29:3-8. DOI: 10.1016/j.ejim.2015.11.026.Gao X, Fan JG. Diagnosis and Management of non-Alcoholic Fatty Liver Disease and Related Metabolic Disorders: Consensus Statement From the Study Group of Liver and Metabolism, Chinese Society of Endocrinology. J Diabetes (2013) 5:406–15. DOI: 10.1111/1753-0407.12056Gao X, Fan JG. Diagnosis and Management of non-Alcoholic Fatty Liver Disease and Related Metabolic Disorders: Consensus Statement From the Study Group of Liver and Metabolism, Chinese Society of Endocrinology. J Diabetes (2013) 5:406–15. DOI: 10.1111/1753-0407.12056Gu Z, Li D, He H, Wang J, Hu X, Zhang P, et al. Body Mass Index, Waist Circumference, and Waist-to-Height Ratio for Prediction of Multiple Metabolic Risk Factors in Chinese Elderly Population. Sci Rep (2018) 8:385. DOI: 10.1038/s41598-017-18854-1.Gu Z, Li D, He H, Wang J, Hu X, Zhang P, et al. Body Mass Index, Waist Circumference, and Waist-to-Height Ratio for Prediction of Multiple Metabolic Risk Factors in Chinese Elderly Population. Sci Rep (2018) 8:385. DOI: 10.1038/s41598-017-18854-1.Tan Y, Liu X, Zhou K, He X, Lu C, He B, et al. The Potential Biomarkers to Identify the Development of Steatosis in Hyperuricemia. PLoS One. 2016;11(2):e0149043. DOI: 10.1371/journal.pone.0149043.Tan Y, Liu X, Zhou K, He X, Lu C, He B, et al. The Potential Biomarkers to Identify the Development of Steatosis in Hyperuricemia. PLoS One. 2016;11(2):e0149043. DOI: 10.1371/journal.pone.0149043.Jensen T, Niwa K, Hisatome I, Kanbay M, Andres-Hernando A, Roncal-Jimenez CA, et al. Increased Serum Uric Acid over five years is a Risk Factor for Developing Fatty Liver. Sci Rep. 2018;8(1):11735. DOI: 10.1038/s41598-018-30267-2.Jensen T, Niwa K, Hisatome I, Kanbay M, Andres-Hernando A, Roncal-Jimenez CA, et al. Increased Serum Uric Acid over five years is a Risk Factor for Developing Fatty Liver. Sci Rep. 2018;8(1):11735. DOI: 10.1038/s41598-018-30267-2.Di Bonito P, Valerio G, Licenziati MR, Miraglia Del Giudice E, Baroni MG, Morandi A, et al. High uric acid, reduced glomerular filtration rate and non-alcoholic fatty liver in young people with obesity. J Endocrinol Invest. 2020;43(4):461-468. DOI: 10.1007/s40618-019-01130-6.Di Bonito P, Valerio G, Licenziati MR, Miraglia Del Giudice E, Baroni MG, Morandi A, et al. High uric acid, reduced glomerular filtration rate and non-alcoholic fatty liver in young people with obesity. J Endocrinol Invest. 2020;43(4):461-468. DOI: 10.1007/s40618-019-01130-6.Zhang Q, Ma X, Xing J, Shi H, Yang R, Jiao Y, et al. Serum Uric Acid Is a Mediator of the Association Between Obesity and Incident Nonalcoholic Fatty Liver Disease: A Prospective Cohort Study. Front Endocrinol (Lausanne). 2021;12:657856. DOI: 10.3389/fendo.2021.657856.Zhang Q, Ma X, Xing J, Shi H, Yang R, Jiao Y, et al. Serum Uric Acid Is a Mediator of the Association Between Obesity and Incident Nonalcoholic Fatty Liver Disease: A Prospective Cohort Study. Front Endocrinol (Lausanne). 2021;12:657856. DOI: 10.3389/fendo.2021.657856.Kurahashi H, Watanabe M, Sugimoto M, Ariyoshi Y, Mahmood S, Araki M, et al. Testosterone replacement elevates the serum uric acid levels in patients with female to male gender identity disorder. Endocr J. 2013;60(12):1321-7. DOI: 10.1507/endocrj.ej13-0203.Kurahashi H, Watanabe M, Sugimoto M, Ariyoshi Y, Mahmood S, Araki M, et al. Testosterone replacement elevates the serum uric acid levels in patients with female to male gender identity disorder. Endocr J. 2013;60(12):1321-7. DOI: 10.1507/endocrj.ej13-0203.Fukai S, Akishita M, Miyao M, Ishida K, Toba K, Ouchi Y. Age-related changes in plasma androgen levels and their association with cardiovascular risk factors in male Japanese office workers. Geriatr Gerontol Int. 2010;10(1):32-9. DOI: 10.1111/j.1447-0594.2009.00552.x.Fukai S, Akishita M, Miyao M, Ishida K, Toba K, Ouchi Y. Age-related changes in plasma androgen levels and their association with cardiovascular risk factors in male Japanese office workers. Geriatr Gerontol Int. 2010;10(1):32-9. DOI: 10.1111/j.1447-0594.2009.00552.x.Petta S, Cammà C, Cabibi D, Di Marco V, Craxì A. Hyperuricemia is associated with histological liver damage in patients with non-alcoholic fatty liver disease. Aliment Pharmacol Ther. 2011;34(7):757-66. DOI: 10.1111/j.1365-2036.2011.04788.x.Petta S, Cammà C, Cabibi D, Di Marco V, Craxì A. Hyperuricemia is associated with histological liver damage in patients with non-alcoholic fatty liver disease. Aliment Pharmacol Ther. 2011;34(7):757-66. DOI: 10.1111/j.1365-2036.2011.04788.x.Mosca A, Nobili V, De Vito R, Crudele A, Scorletti E, Villani A, et al. Serum uric acid concentrations and fructose consumption are independently associated with NASH in children and adolescents. J Hepatol. 2017;66(5):1031-1036. DOI: 10.1016/j.jhep.2016.12.025.Mosca A, Nobili V, De Vito R, Crudele A, Scorletti E, Villani A, et al. Serum uric acid concentrations and fructose consumption are independently associated with NASH in children and adolescents. J Hepatol. 2017;66(5):1031-1036. DOI: 10.1016/j.jhep.2016.12.025.Jaruvongvanich V, Ahuja W, Wirunsawanya K, Wijarnpreecha K, Ungprasert P. Hyperuricemia is associated with nonalcoholic fatty liver disease activity score in patients with nonalcoholic fatty liver disease: a systematic review and meta-analysis. Eur J Gastroenterol Hepatol. 2017;29(9):1031-1035. DOI: 10.1097/MEG.0000000000000931.Jaruvongvanich V, Ahuja W, Wirunsawanya K, Wijarnpreecha K, Ungprasert P. Hyperuricemia is associated with nonalcoholic fatty liver disease activity score in patients with nonalcoholic fatty liver disease: a systematic review and meta-analysis. Eur J Gastroenterol Hepatol. 2017;29(9):1031-1035. DOI: 10.1097/MEG.0000000000000931.Yoneda M, Thomas E, Sumida Y, Imajo K, Hyogo H, Fujii H, et al. Uric acid levels decrease with fibrosis progression in patients with nonalcoholic fatty liver disease. Clin Biochem. 2014;47(12):1138-9. DOI: 10.1016/j.clinbiochem.2014.04.026.Yoneda M, Thomas E, Sumida Y, Imajo K, Hyogo H, Fujii H, et al. Uric acid levels decrease with fibrosis progression in patients with nonalcoholic fatty liver disease. Clin Biochem. 2014;47(12):1138-9. DOI: 10.1016/j.clinbiochem.2014.04.026.Huang JF, Yeh ML, Yu ML, Huang CF, Dai CY, Hsieh MY, et al. Hyperuricemia Inversely Correlates with Disease Severity in Taiwanese Nonalcoholic Steatohepatitis Patients. PLoS One. 2015;10(10):e0139796. DOI: 10.1371/journal.pone.0139796.Huang JF, Yeh ML, Yu ML, Huang CF, Dai CY, Hsieh MY, et al. Hyperuricemia Inversely Correlates with Disease Severity in Taiwanese Nonalcoholic Steatohepatitis Patients. PLoS One. 2015;10(10):e0139796. DOI: 10.1371/journal.pone.0139796.Jaruvongvanich V, Ahuja W, Wijarnpreecha K, Ungprasert P. Hyperuricemia is not associated with severity of liver fibrosis in patients with nonalcoholic fatty liver disease: a systematic review and meta-analysis. Eur J Gastroenterol Hepatol. 2017;29(6):694-697. DOI: 10.1097/MEG.0000000000000865.Jaruvongvanich V, Ahuja W, Wijarnpreecha K, Ungprasert P. Hyperuricemia is not associated with severity of liver fibrosis in patients with nonalcoholic fatty liver disease: a systematic review and meta-analysis. Eur J Gastroenterol Hepatol. 2017;29(6):694-697. DOI: 10.1097/MEG.0000000000000865.Zhou M, Yang N, Xing X, Chang D, Li J, Deng J, et al. Obesity interacts with hyperuricemia on the severity of non-alcoholic fatty liver disease. BMC Gastroenterol. 2021;21(1):43. DOI: 10.1186/s12876-021-01615-w.Zhou M, Yang N, Xing X, Chang D, Li J, Deng J, et al. Obesity interacts with hyperuricemia on the severity of non-alcoholic fatty liver disease. BMC Gastroenterol. 2021;21(1):43. DOI: 10.1186/s12876-021-01615-w.Palmer TM, Nordestgaard BG, Benn M, Tybjærg-Hansen A, Davey Smith G, Lawlor DA, et al. Association of plasma uric acid with ischaemic heart disease and blood pressure: mendelian randomisation analysis of two large cohorts. BMJ. 2013;347:f4262. DOI: 10.1136/bmj.f4262.Palmer TM, Nordestgaard BG, Benn M, Tybjærg-Hansen A, Davey Smith G, Lawlor DA, et al. Association of plasma uric acid with ischaemic heart disease and blood pressure: mendelian randomisation analysis of two large cohorts. BMJ. 2013;347:f4262. DOI: 10.1136/bmj.f4262.Norvik JV, Storhaug HM, Ytrehus K, Jenssen TG, Zykova SN, Eriksen BO, et al. Overweight modifies the longitudinal association between uric acid and some components of the metabolic syndrome: The Tromsø Study. BMC Cardiovasc Disord. 2016;16:85. DOI: 10.1186/s12872-016-0265-8.Norvik JV, Storhaug HM, Ytrehus K, Jenssen TG, Zykova SN, Eriksen BO, et al. Overweight modifies the longitudinal association between uric acid and some components of the metabolic syndrome: The Tromsø Study. BMC Cardiovasc Disord. 2016;16:85. DOI: 10.1186/s12872-016-0265-8.Yu TY, Jee JH, Bae JC, Jin SM, Baek JH, Lee MK, et al. Serum uric acid: A strong and independent predictor of metabolic syndrome after adjusting for body composition. Metabolism. 2016;65(4):432-40. DOI: 10.1016/j.metabol.2015.11.003.Yu TY, Jee JH, Bae JC, Jin SM, Baek JH, Lee MK, et al. Serum uric acid: A strong and independent predictor of metabolic syndrome after adjusting for body composition. Metabolism. 2016;65(4):432-40. DOI: 10.1016/j.metabol.2015.11.003.Lanaspa MA, Cicerchi C, Garcia G, Li N, Roncal-Jimenez CA, Rivard CJ, et al. Counteracting roles of AMP deaminase and AMP kinase in the development of fatty liver. PLoS One. 2012;7(11):e48801. DOI: 10.1371/journal.pone.0048801.Lanaspa MA, Cicerchi C, Garcia G, Li N, Roncal-Jimenez CA, Rivard CJ, et al. Counteracting roles of AMP deaminase and AMP kinase in the development of fatty liver. PLoS One. 2012;7(11):e48801. DOI: 10.1371/journal.pone.0048801.Cicerchi C, Li N, Kratzer J, Garcia G, Roncal-Jimenez CA, Tanabe K, et al. Uric acid-dependent inhibition of AMP kinase induces hepatic glucose production in diabetes and starvation: evolutionary implications of the uricase loss in hominids. FASEB J. 2014;28(8):3339-50. DOI: 10.1096/fj.13-243634.Cicerchi C, Li N, Kratzer J, Garcia G, Roncal-Jimenez CA, Tanabe K, et al. Uric acid-dependent inhibition of AMP kinase induces hepatic glucose production in diabetes and starvation: evolutionary implications of the uricase loss in hominids. FASEB J. 2014;28(8):3339-50. DOI: 10.1096/fj.13-243634.Lanaspa MA, Epperson LE, Li N, Cicerchi C, Garcia GE, Roncal-Jimenez CA, et al. Opposing activity changes in AMP deaminase and AMP-activated protein kinase in the hibernating ground squirrel. PLoS One. 2015;10(4):e0123509. DOI: 10.1371/journal.pone.0123509.Lanaspa MA, Epperson LE, Li N, Cicerchi C, Garcia GE, Roncal-Jimenez CA, et al. Opposing activity changes in AMP deaminase and AMP-activated protein kinase in the hibernating ground squirrel. PLoS One. 2015;10(4):e0123509. DOI: 10.1371/journal.pone.0123509.Lanaspa MA, Sanchez-Lozada LG, Choi YJ, Cicerchi C, Kanbay M, Roncal-Jimenez CA, et al. Uric acid induces hepatic steatosis by generation of mitochondrial oxidative stress: potential role in fructose-dependent and -independent fatty liver. J Biol Chem. 2012;287(48):40732-44. DOI: 10.1074/jbc.M112.399899.Lanaspa MA, Sanchez-Lozada LG, Choi YJ, Cicerchi C, Kanbay M, Roncal-Jimenez CA, et al. Uric acid induces hepatic steatosis by generation of mitochondrial oxidative stress: potential role in fructose-dependent and -independent fatty liver. J Biol Chem. 2012;287(48):40732-44. DOI: 10.1074/jbc.M112.399899.Choi YJ, Shin HS, Choi HS, Park JW, Jo I, Oh ES, et al. Uric acid induces fat accumulation via generation of endoplasmic reticulum stress and SREBP-1c activation in hepatocytes. Lab Invest. 2014;94(10):1114-25. DOI: 10.1038/labinvest.2014.98.Choi YJ, Shin HS, Choi HS, Park JW, Jo I, Oh ES, et al. Uric acid induces fat accumulation via generation of endoplasmic reticulum stress and SREBP-1c activation in hepatocytes. Lab Invest. 2014;94(10):1114-25. DOI: 10.1038/labinvest.2014.98.Pacher P, Nivorozhkin A, Szabó C. Therapeutic effects of xanthine oxidase inhibitors: renaissance half a century after the discovery of allopurinol. Pharmacol Rev. 2006;58(1):87-114. DOI: 10.1124/pr.58.1.6.Pacher P, Nivorozhkin A, Szabó C. Therapeutic effects of xanthine oxidase inhibitors: renaissance half a century after the discovery of allopurinol. Pharmacol Rev. 2006;58(1):87-114. DOI: 10.1124/pr.58.1.6.Cicoira M, Zanolla L, Rossi A, Golia G, Franceschini L, Brighetti G, et al. Elevated serum uric acid levels are associated with diastolic dysfunction in patients with dilated cardiomyopathy. Am Heart J. 2002;143(6):1107-11. DOI: 10.1067/mhj.2002.122122.Cicoira M, Zanolla L, Rossi A, Golia G, Franceschini L, Brighetti G, et al. Elevated serum uric acid levels are associated with diastolic dysfunction in patients with dilated cardiomyopathy. Am Heart J. 2002;143(6):1107-11. DOI: 10.1067/mhj.2002.122122.Gibbings S, Elkins ND, Fitzgerald H, Tiao J, Weyman ME, Shibao G, et al. Xanthine oxidoreductase promotes the inflammatory state of mononuclear phagocytes through effects on chemokine expression, peroxisome proliferator-activated receptor-{gamma} sumoylation, and HIF-1{alpha}. J Biol Chem. 2011;286(2):961-75. DOI: 10.1074/jbc.M110.150847.Gibbings S, Elkins ND, Fitzgerald H, Tiao J, Weyman ME, Shibao G, et al. Xanthine oxidoreductase promotes the inflammatory state of mononuclear phagocytes through effects on chemokine expression, peroxisome proliferator-activated receptor-{gamma} sumoylation, and HIF-1{alpha}. J Biol Chem. 2011;286(2):961-75. DOI: 10.1074/jbc.M110.150847.iu Z, Que S, Zhou L, Zheng S. Dose-response Relationship of Serum Uric Acid with Metabolic Syndrome and Non-alcoholic Fatty Liver Disease Incidence: A Meta-analysis of Prospective Studies. Sci Rep. 2015;5:14325. DOI: 10.1038/srep14325.iu Z, Que S, Zhou L, Zheng S. Dose-response Relationship of Serum Uric Acid with Metabolic Syndrome and Non-alcoholic Fatty Liver Disease Incidence: A Meta-analysis of Prospective Studies. Sci Rep. 2015;5:14325. DOI: 10.1038/srep14325.Yuan H, Yu C, Li X, Sun L, Zhu X, Zhao C, et al. Serum Uric Acid Levels and Risk of Metabolic Syndrome: A Dose-Response Meta-Analysis of Prospective Studies. J Clin Endocrinol Metab. 2015;100(11):4198-207. DOI: 10.1210/jc.2015-2527.Yuan H, Yu C, Li X, Sun L, Zhu X, Zhao C, et al. Serum Uric Acid Levels and Risk of Metabolic Syndrome: A Dose-Response Meta-Analysis of Prospective Studies. J Clin Endocrinol Metab. 2015;100(11):4198-207. DOI: 10.1210/jc.2015-2527.Kocak MZ, Aktas G, Erkus E, Sincer I, Atak B, Duman T. Serum uric acid to HDL-cholesterol ratio is a strong predictor of metabolic syndrome in type 2 diabetes mellitus. Rev Assoc Med Bras (1992). 2019;65(1):9-15. DOI: 10.1590/1806-9282.65.1.9.Kocak MZ, Aktas G, Erkus E, Sincer I, Atak B, Duman T. Serum uric acid to HDL-cholesterol ratio is a strong predictor of metabolic syndrome in type 2 diabetes mellitus. Rev Assoc Med Bras (1992). 2019;65(1):9-15. DOI: 10.1590/1806-9282.65.1.9.Zhang YN, Wang QQ, Chen YS, Shen C, Xu CF. Association between Serum Uric Acid to HDL-Cholesterol Ratio and Nonalcoholic Fatty Liver Disease in Lean Chinese Adults. Int J Endocrinol. 2020;2020:5953461. DOI: 10.1155/2020/5953461.Zhang YN, Wang QQ, Chen YS, Shen C, Xu CF. Association between Serum Uric Acid to HDL-Cholesterol Ratio and Nonalcoholic Fatty Liver Disease in Lean Chinese Adults. Int J Endocrinol. 2020;2020:5953461. DOI: 10.1155/2020/5953461.Calcaterra V, Brambilla P, Maffè GC, Klersy C, Albertini R, Introzzi F, et al. Metabolic syndrome in Turner syndrome and relation between body composition and clinical, genetic, and ultrasonographic characteristics. Metab Syndr Relat Disord. 2014;12(3):159-64. DOI: 10.1089/met.2013.0075.Calcaterra V, Brambilla P, Maffè GC, Klersy C, Albertini R, Introzzi F, et al. Metabolic syndrome in Turner syndrome and relation between body composition and clinical, genetic, and ultrasonographic characteristics. Metab Syndr Relat Disord. 2014;12(3):159-64. DOI: 10.1089/met.2013.0075.Wang N, Rao JJ, Dong H, Qi JP. [The application of proton magnetic resonance spectroscopy and computerized tomography in evaluating nonalcoholic fatty liver disease]. Zhonghua Gan Zang Bing Za Zhi. 2008;16(7):528-31. (In Chinese). PMID: 18647533.Wang N, Rao JJ, Dong H, Qi JP. [The application of proton magnetic resonance spectroscopy and computerized tomography in evaluating nonalcoholic fatty liver disease]. Zhonghua Gan Zang Bing Za Zhi. 2008;16(7):528-31. (In Chinese). PMID: 18647533.Krishan S. Correlation between non-alcoholic fatty liver disease (NAFLD) and dyslipidemia in type 2 diabetes. Diabetes Metab Syndr. 2016;10(2 Suppl 1):S77-81. DOI: 10.1016/j.dsx.2016.01.034.Krishan S. Correlation between non-alcoholic fatty liver disease (NAFLD) and dyslipidemia in type 2 diabetes. Diabetes Metab Syndr. 2016;10(2 Suppl 1):S77-81. DOI: 10.1016/j.dsx.2016.01.034.Kosekli MA, Kurtkulagii O, Kahveci G, Duman TT, Tel BMA, Bilgin S, et al. The association between serum uric acid to high density lipoprotein-cholesterol ratio and nonalcoholic fatty liver disease: the abund study. Rev Assoc Med Bras (1992). 2021;67(4):549-554. DOI: 10.1590/1806-9282.20201005.Kosekli MA, Kurtkulagii O, Kahveci G, Duman TT, Tel BMA, Bilgin S, et al. The association between serum uric acid to high density lipoprotein-cholesterol ratio and nonalcoholic fatty liver disease: the abund study. Rev Assoc Med Bras (1992). 2021;67(4):549-554. DOI: 10.1590/1806-9282.20201005.Seo YB, Han AL. Association of the Serum Uric Acid-to-Creatinine Ratio with Nonalcoholic Fatty Liver Disease Diagnosed by Computed Tomography. Metab Syndr Relat Disord. 2021;19(2):70-75. DOI: 10.1089/met.2020.0086.Seo YB, Han AL. Association of the Serum Uric Acid-to-Creatinine Ratio with Nonalcoholic Fatty Liver Disease Diagnosed by Computed Tomography. Metab Syndr Relat Disord. 2021;19(2):70-75. DOI: 10.1089/met.2020.0086.

The authors declare that there are no conflicts of interest present.